Futu Information on December 8 | Hong Kong stocks were strong throughout the day, with the Hang Seng Index up 3.38%, the Hang Seng Index up 6.64% and the National Index up 3.63%.

By the end of the day, Hong Kong stocks were up 1421, down 523 to close flat at 1006.

The specific industry performance is shown below:

Plate aspectScience and Internet stocks rose collectively.Bilibili Inc. soared by more than 22%, Kuaishou Technology by more than 11%, Tencent and Meituan by about 6%, and BABA by more than 5%.

Internet medical stocks are strong throughout the day.Alibaba Health Information Technology rose by more than 16%, Ping An Healthcare And Technology by more than 13% and JD Health by more than 12%.

Gambling stocks rose generally.Wynn Macau rose by more than 22%, Sands China by 10% and Galaxy Entertainment by more than 5%.

Tobacco concept stocks roseChina Tobacco rose more than 16% in Hong Kong and nearly 12% in Smoore International Holdings Limited.

Real estate and property management stocks pull up hand in handXuhui Holdings rose nearly 10%, Country Garden Holdings rose more than 5%, Sunac Services rose more than 9%, Country Garden Services Holdings rose more than 6%.

Catering stocks rose.Helens rose by 8%, 99%, Haidilao International Holding by more than 6%, and quack by nearly 9%.

Individual stocks$BILIBILI-W (09626.HK)$It rose by more than 22%, institutions reduced costs and increased efficiency to boost expectations, and profits continued to improve quarter by quarter.

$KUAISHOU-W (01024.HK)$Up more than 11%, BoCom maintained Kuaishou Technology's buying rating, saying it was expected to turn losses into profits ahead of schedule.

Alibaba Health Information Technology (00241.HK) $rose by more than 16%, and the demand for online medicine consultation broke out, which helped to cultivate residents' habit of seeking medical treatment online.

$TRAD CHI MED (00570.HK)$With an increase of more than 16%, Sinopharm is considering privatizing it at a 59% premium.

$SANDS CHINA LTD (01928.HK)$Up 10%, on the news, the Macao SAR response Coordination Center will hold an epidemic press conference at 5 pm today to introduce the latest epidemic situation of novel coronavirus and the latest prevention and control measures in Macao.

Today's turnover of Hong Kong shares TOP20

Institutional viewpoint

• Xiao Mo: the potential net profit of internal insurance stocks in the fourth quarter may be better than expected, and Ping An Insurance is the first choice for the industry.

According to a research report released by Xiaomo, the mainland's accelerated optimization of the epidemic, a rebound in bond yields and adequate solvency capital appear to support positive sentiment and attractive dividend yields. The bank expects the potential net profit of domestic insurance stocks to be better than expected in the fourth quarter of this year as the mainland stock market recovers, reiterating$PING AN (02318.HK)$及$CHINA LIFE (02628.HK)$First choice for the industry.

• Xiaomo: resource stocks still have a lot of room for improvement, and investors are advised to find the bottom, Anhui Conch Cement and so on.

Xiaomo released a research report saying that since the optimization of epidemic prevention policies began last month, mainland resource stocks have rebounded by 27%. The bank believes that as the mainland continues to return to normal, resource stocks still have a lot of room to rise. Commodity and resource stocks are likely to be driven by policy news in the near future, and the recovery in demand after the Spring Festival will be the first set of data to confirm whether the industry can return to pre-epidemic levels, the report said. The bank continued to advise investors to make a bottom.$CONCH CEMENT (00914.HK)$ 、$CNBM (03323.HK)$、$ANGANG STEEL (00347.HK)$ 、$ND PAPER (02689.HK)$ 。

• Daiwa: reiterate Kang Bio-B buy rating, and the target price rises to HK $43.

Daiwa issued a research report, reiterating$AKESO, INC. - B (09926.HK)$The "Buy" rating, which recently announced a licensing agreement with Summit Therapeutics for Ivosi (AK112,PD-1/VEGF bispecific), involves $5 billion. Given that the US $5 billion will be accounted for next year, the target price will be raised by 10.3 per cent from HK $39 to HK $43.

• Morgan Stanley: increase the holding rating of Cat's Eye Entertainment, raising the target price of IMAX China to HK $6.90

According to a research report released by Morgan Stanley,$Maoyan Entertainment (01896.HK)$The "overweight" rating was raised from HK $7.5 to HK $9.4. It is also given a "keep up with the market" rating of IMAX China (01970), with the target price rising from HK $6.10 to HK $6.90. With the coming holiday and other positive factors, film stocks are expected to further improve in the near future, in view of strong fundamentals and rich short-term catalysts, the preferred Cat's Eye Entertainment.

For more popular sections, please see "Futu Niuniu app- Market-Thermal Map":